Utility of Hepatitis C Viral Load Monitoring on Direct-Acting Antiviral Therapy

June 21, 2015 at 7:45 pm

Clin Infect Dis June 15, 2015 V.60 N.12  P.1743-1751

Editor’s Choice

Sreetha Sidharthan, Anita Kohli, Zayani Sims, Amy Nelson, Anu Osinusi, Henry Masur, and Shyam Kottilil

During hepatitis C virus (HCV) treatment with interferon-sparing direct-acting antiviral regimens, low-level quantifiable HCV RNA after completion of therapy does not preclude treatment success. Patients with detectable viremia at week 4 of treatment also have high sustained virologic response rates.

PDF

http://cid.oxfordjournals.org/content/60/12/1743.full.pdf+html

Entry filed under: Antivirales no HIV, Biología Molecular, Epidemiología, Hepatitis C, Infecciones virales, Metodos diagnosticos, Update. Tags: .

Burden of bacterial resistance among neonatal infections in low income countries: how convincing is the epidemiological evidence? Comparison of the Metabolic Effects of Ritonavir-Boosted Darunavir or Atazanavir Versus Raltegravir, and the Impact of Ritonavir Plasma Exposure: ACTG 5257


Calendar

June 2015
M T W T F S S
« May   Jul »
1234567
891011121314
15161718192021
22232425262728
2930  

Most Recent Posts


%d bloggers like this: